1.42
+0.015(+1.07%)
Currency In USD
| Previous Close | 1.4 |
| Open | 1.4 |
| Day High | 1.43 |
| Day Low | 1.38 |
| 52-Week High | 1.66 |
| 52-Week Low | 0.28 |
| Volume | 1.16M |
| Average Volume | 2.31M |
| Market Cap | 514.21M |
| PE | -7.45 |
| EPS | -0.19 |
| Moving Average 50 Days | 1.42 |
| Moving Average 200 Days | 0.95 |
| Change | 0.02 |
If you invested $1000 in Lexicon Pharmaceuticals, Inc. (LXRX) 10 years ago, it would be worth $104.97 as of December 04, 2025 at a share price of $1.415. Whereas If you bought $1000 worth of Lexicon Pharmaceuticals, Inc. (LXRX) shares 5 years ago, it would be worth $895.57 as of December 04, 2025 at a share price of $1.415.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
GlobeNewswire Inc.
Nov 25, 2025 1:30 PM GMT
THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, De
Lexicon Pharmaceuticals to Participate at the Jefferies 2025 London Healthcare Conference
GlobeNewswire Inc.
Nov 11, 2025 1:30 PM GMT
THE WOODLANDS, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Jefferies 2025 London Healthcare Conference on Tuesday, November
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
GlobeNewswire Inc.
Nov 08, 2025 7:30 PM GMT
Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of lifeTHE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Na